TOT BIOPHARM International Company Limited
HKEX:1875.HK
Overview | Financials
Company Name | TOT BIOPHARM International Company Limited |
Symbol | 1875.HK |
Currency | HKD |
Price | 1.74 |
Market Cap | 1,221,752,787 |
Dividend Yield | 0% |
52-week-range | 1.48 - 2.79 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Jun Liu |
Website | https://www.totbiopharm.com |
An error occurred while fetching data.
About TOT BIOPHARM International Company Limited
TOT BIOPHARM International Company Limited, an investment holding company, engages in the research and development, manufacture, and marketing of anti-tumor drugs in the People's Republic of China. The company's principal drug candidate is TAB008 for the treatment of non-squamous non-small-cell lung cancer metastatic colorectal cancer, glioblastoma multiforme, ovarian cancer, cervical
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD